Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K042542
    Date Cleared
    2005-01-10

    (112 days)

    Product Code
    Regulation Number
    866.4700
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    CYTOVISION FOR CEP XY

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Applied Imaging CytoVision™ system is an automated scanning microscope and image analysis system. It is intended for in vitro diagnostic use as an aid in chromosomal analysis. Cyto Vision assists in the location of interphase and metaphase nuclei on standard microscope slides using both brightfield and fluorescent microscopy.

    This particular CytoVision software application is an accessory to the CEP® X Spectrum Orange™/CEP® Y Spectrum Green™ DNA Probe kit (Vysis, Inc. Downer's Grove, IL) and is limited to the analysis of CEP XY probes via high magnification capture and analysis of interphase nuclei. CEP XY is indicated for use to assess the effectiveness of bone marrow transplantation in opposite-sex transplants.

    Device Description

    The Applied Imaging CytoVision™ system is an automated scanning microscope and image analysis system. It is intended for in vitro diagnostic use as an aid in chromosomal analysis. Cyto Vision assists in the location of interphase and metaphase nuclei on standard microscope slides using both brightfield and fluorescent microscopy.

    AI/ML Overview

    This letter does not provide the detailed study results needed to complete all sections of your request. It's a 510(k) clearance letter, which confirms substantial equivalence to a predicate device, not a full summary of performance studies.

    However, based on the provided text, here's what can be extracted:

    1. A table of acceptance criteria and the reported device performance

    This information is not provided in the given document. The letter states "We have reviewed your Section 510(k) premarket notification... and have determined the device is substantially equivalent," implying that performance data was submitted, but the specific acceptance criteria and reported device performance are not detailed here.

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    This information is not provided in the given document.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    This information is not provided in the given document.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    This information is not provided in the given document.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This information is not provided in the given document. The device is described as an "automated scanning microscope and image analysis system" that "assists in the location of interphase and metaphase nuclei," suggesting it operates as an aid, but no MRMC study details or effect sizes are mentioned.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    The device is described as an "automated scanning microscope and image analysis system" that "assists in the location of interphase and metaphase nuclei." The "Indications For Use" state it is an "aid in chromosomal analysis" and "assists in the location of interphase and metaphase nuclei." This implies it's not a fully standalone diagnostic device but rather a tool to support human analysis. However, a standalone performance study of the algorithm within its assisting role is not explicitly described or quantified in this document.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    This information is not provided in the given document. The device is used with the "CEP® X Spectrum Orange™/CEP® Y Spectrum Green™ DNA Probe kit" for "analysis of CEP XY probes" to "assess the effectiveness of bone marrow transplantation." This suggests the ground truth would likely be related to the actual chromosomal status or transplant success, but how that ground truth was established for a study is not detailed.

    8. The sample size for the training set

    This information is not provided in the given document.

    9. How the ground truth for the training set was established

    This information is not provided in the given document.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1